Worldwide distributor of NSN parts and consumables located in the USA.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Diagnostic or lab reagents on a backing, prepared diag/lab reagents whether or not on a backing, not of heading 3002 or 3006; certified ref materials
Composite diagnostic or laboratory reagents, n.E.S.
Chemicals-other
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
000000 - No nmfc freight description
534 - Medical supplies (not requiring temperature control)
9 - Other or no special handling required (sh)
A - Shipment is not a consolidation and does not exceed 84 inches in any dimension.
M - Medical supplies, equipment, samples, records, etc.
Q - Subject to damage from freezing
Z - No rating
Questions & Answers: |
|
What are the historical prices recorded for this stock number? | |
Historical data shows pricing from $505.97 to $843.28.. | |
Does NSN 6550-01-162-1392 have a shelf life? | |
No. There is no shelf life applicable for this NSN. | |
What NATO entities are users of this NSN? | |
Department Of The Army, Department Of The Air Force, and Department Of The Navy | |
What is the NIIN of NSN 6550-01-162-1392? | |
011621392 or 01-162-1392 | |
Does NSN 6550-01-162-1392 require demilitarization? | |
Yes - ITAR Controlled | |
What is the most recent solicitation for NSN 6550-01-162-1392? | |
No solicitations for this NSN. | |
When was this national stock number assigned to the federal catalog? | |
Sep 14, 1983 |
Routes of entry: inhalation: no skin: no ingestion: no
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: the control sera have been prepared
from human blood that was nonreactive when tested for hepatitis b
surface antigen & hiv antibody. However, no test method can offer
complete assurance. Controls & a ll blood specimens should be
handled asif capable of transmitting disease.
explanation of carcinogenicity: none
effects of overexposure: the control sera have been prepared from human
blood that was nonreactive when tested for hepatitis b surface
antigen & hiv antibody. However, no test method can offer complete
assurance. Controls & a ll body specimens should be handled as if
capable of transmitting disease.
First aid: skin: wash w/soap & water. Eyes: flush w/plenty of water.
ingestion: obtain medical attention in all cases.
Stability indicator/materials to avoid: yes
lead or copper
hazardous decomposition products: poisonous gas
Waste disposal methods: place in sealed containers. Avoid disposing
material down drains. Flush w/large volume of water to prevent
azide build-up in copper or lead plumbing. Dispose of in accorance
w/federal, state, & local regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: sodium azide, azide
cas: 26628-22-8
rtecs #: vy8050000
fraction by wt: 0.10%
other rec limits: 0.1 ppm
osha pel: 0.1 ppm
acgih tlv: c 0.29 mg/cum
epa rpt qty: 1000 lbs
dot rpt qty: 1000 lbs